⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL691744 | 0.71 | — | — | |
| SCHEMBL115390 | 0.69 | — | — | |
| SCHEMBL8529510 | 0.69 | — | — | |
| SCHEMBL20526451 | 0.69 | ALOX5 (0.39) | — | |
| Methylene Chloride SCHEMBL27333999 | 0.67 | KDM4E (0.38) | — | |
| Hydrochloric Acid SCHEMBL29135193 | 0.67 | — | — | |
| SCHEMBL9686374 | 0.65 | — | — | |
| SCHEMBL21720192 | 0.65 | — | — | |
| SCHEMBL21737541 | 0.65 | — | — | |
| SCHEMBL11522722 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4273147-A1 | SUBSTITUTED SPIROLACTAMS, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | Bayer Aktiengesellschaft (DE) | 2023-11-08 | — | — | EP | disclosed |
| US-11796428-B2 | Compressed open flow assay and use | ESSENLIX CORPORATION (US) | 2023-10-24 | — | — | US | disclosed |
| EP-3341724-B1 | DEVICE AND SYSTEM FOR COLLECTING AND ANALYZING VAPOR CONDENSATE, PARTICULARLY EXHALED BREATH CONDENSATE, AS WELL AS METHOD OF USING THE SAME | ESSENLIX CORP (US) | 2023-10-04 | — | — | EP | disclosed |
| US-11760762-B2 | Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors | SIGNALRX PHARMACEUTICALS, INC. (US) | 2023-09-19 | — | — | US | disclosed |
| US-20230077906-A1 | ASSAY FOR VAPOR CONDENSATES | ESSENLIX CORPORATION (US) | 2023-03-16 | — | — | US | disclosed |
| US-11523752-B2 | Assay for vapor condensates | ESSENLIX CORPORATION (US) | 2022-12-13 | — | — | US | disclosed |
| US-20210186021-A1 | DIAMINOTRIAZINE COMPOUNDS | BASF SE (DE) | 2021-06-24 | — | — | US | disclosed |
| US-20210072122-A1 | COMPRESSED OPEN FLOW ASSAY AND USE | ESSENLIX CORPORATION (US) | 2021-03-11 | — | — | US | disclosed |
| US-20210041416-A1 | RAPID VAPOR CONDENSATE COLLECTION AND ANALYSIS | ESSENLIX CORPORATION (US) | 2021-02-11 | — | — | US | disclosed |
| US-10830761-B2 | Device and system for collecting and analyzing vapor condensate, particularly exhaled breath condensate, as well as method of using the same | ESSENLIX CORPORATION (US) | 2020-11-10 | — | — | US | disclosed |
| EP-1574165-A2 | Fiber optic probe placement guide | Sensys Medical, Inc. (US) | 2005-09-14 | — | — | EP | disclosed |
| EP-1278453-A2 | FIBER OPTIC PROBE PLACEMENT GUIDE | Instrumentation Metrics, Inc. (US) | 2003-01-29 | — | — | EP | disclosed |
| US-6415167-B1 | Fiber optic probe placement guide | INSTRUMENTATION METRICS, INC. | 2002-07-02 | — | — | US | disclosed |
| WO-2001082794-A2 | FIBER OPTIC PROBE PLACEMENT GUIDE | SENSYS MEDICAL, INC. (US) | 2001-11-08 | — | — | WO | disclosed |
| US-5051429-A | For treatment of autoimmune diseases such as arthritis, lupus, antiinflammatory agents, multiple sclerosis, diabetes and viral diseases | WARNER-LAMBERT CO. (US) | 1991-09-24 | — | — | US | disclosed |
| US-4992534-A | Anticarcinogenic agents with better water solubility, low toxicity, absorption and stability | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-02-12 | — | — | US | disclosed |
| US-4952693-A | TREATING AUTOIMMUNE DISEASES | WARNER-LAMBERT COMPANY (US) | 1990-08-28 | — | — | US | disclosed |
| EP-0303269-A2 | 2'-Deoxy-5-fluorouridine derivatives, process for preparing the same and the use thereof | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1989-02-15 | — | — | EP | disclosed |
| US-4772606-A | AUTOIMMUNE DISEASES, ORGAN TRANSPLANTS | WARNER-LAMBERT COMPANY (US) | 1988-09-20 | — | — | US | disclosed |
| EP-0178178-A2 | Purine derivatives | WARNER-LAMBERT COMPANY (US) | 1986-04-16 | — | — | EP | disclosed |